TETANUS
1
DEFINATION
Tetanus is caused by a powerful
neurotoxin (tetanospasmin)
produced by strains of “Clostridium
tetani” when introduced into the
tissues that blocks the inhibitory
“synapses on motor neurons in
CNS”, resulting in unrestrained reflex
spasm.
P/B :- DR NIYATI PATEL
2
PATHOLOGY
 The toxin travels up local motor axons from the site of infection 
causing local tetanus and spreads through the blood stream  to
reach many axons and hence the CNS.
 Cranial nerves are usually affected because they are shorter 
hence the common initial presentation is lock-jaw.
P/B :- DR NIYATI PATEL
3
PREDISPOSING FACTORS
 Punctured or war wounds.
 Otitis media.
 Unsterile surgery including use of infected cat gut and swabs,
criminal abortions, ritual circumcision, and ear piercing.
 Bowel surgery and infarction of bowel.
 Burns.
 Animal bites and stings.
 Firework injuries.
 Intra-uterine death.
 Unsterile division of umbilical cord.
 Compound fractures.
 Miscellaneous – Chronic skin ulcers, plaster sores, gangrenous limbs,
eye infections, human bites, dental extractions.
P/B :- DR NIYATI PATEL
4
CLINICAL FEATURES
 Incubation period – usually 6 to 10 days, rarely
several months.
 Clinical Features
1. Prodromal symptoms – Nonspecific such as malaise,
fever, sweating, headache and irritability.
2. Presenting symptoms – Trismus (lock jaw) and
dysphagia (often described as sore throat) due to
painful rigidity of masseters and muscles of deglutition.
Pain and stiffness in the neck and back.
3. Symptoms of established disease – Rigidity, muscle
spasms, symptoms due to sympathetic overactivity
P/B :- DR NIYATI PATEL
5
CLINICAL VARIANTS
 LOCAL TETANUS  INJURY OF LIMB
 ASCENDING FORM  LOCAL SPASM
 CEPHALIC TETANUS  HEAD & NECK INJURY &
INFECTIONS OF EYE & ORBIT  7TH CN AFFECTED
 SPLANCHNIC TETANUS  ABDOMINAL / THORACIC
WOUND  MAINLY POST OPERATIVE
 NEONATAL TETANUS  DUE TO UMBILICAL STUMP
P/B :- DR NIYATI PATEL
6
SEVERITY OF TETANUS GRADING
 GRADE- 1 (MILD) Mild & moderate lock jaw, generalized
spasticity, no spasms / respiratory difficulty
 GRADE-2 (MODERATE)  Well marked rigidity, brief spasm, mild
dysphagia, tachypnoea
 GRADE-3 (SEVERE) Severe trismus, generalized spasticity,
prolonged spasms often spontaneous, tachypnoea (> 40/min),
apnoeic spells, marked dysphagia, tachycardia
 GRADE-4 (VERY SEVERE)  severe hypertension and
tachycardia alternating with relative hypotension and
bradycardia, or severe persistent hypertension or hypotension.
P/B :- DR NIYATI PATEL
7
DIAGNOSIS
 Is confirmed by microbiology. A tissue sample
(preferably) or a swab of the wound site is taken for
Gram-staining and anaerobic culture.
 Cultures of C. tetani are tested for toxin production
P/B :- DR NIYATI PATEL
8
MANAGEMENT
 Neutralization of unbound toxin – Hyperimmune human anti-
tetanus immunoglobulin
 Reduction of further toxin production –
 (a) Care of the wound – Removal of foreign material and debridement
of non-viable tissue of entry wound.
 (b) Antibiotic – Benzyl penicillin / erythromycin
 Control of rigidity & tetanic seizures
 (a) Avoidance of provocative stimuli –such as noise, unnecessary
movement, and keeping injections to minimum.
 (b) Sedative drugs – Diazepam, chlorpromazine, morphine sulphate
 (c) Tracheostomy  not controlled with conservative sedative
regimen
 (d) Induced paralysis with ventilatory support – Neuroparalytic agents
pancuronium
P/B :- DR NIYATI PATEL
9
 Nursing support –
 (a) ICU – Moderate and severe cases should be nursed
in ICU.
 (b) Nutrition – Continuous drip feeding via nasogastric
or nasojejunal tube.
 General measures and physiotherapy – to prevent
bed sores and complications of prolonged
unconsciousness.
 Low molecular weight heparin  to prevent deep vein
thrombosis.
P/B :- DR NIYATI PATEL
10
 Management according to severity of tetanus –
 Mild: Sedatives + Muscle relaxants
 Moderate: Sedatives + Muscle relaxants +
tracheostomy
 Severe: Sedatives + tracheostomy + neuromuscular
paralytic agents + ventilatory support
P/B :- DR NIYATI PATEL
11
PREVENTION
1. Immunization –
 (a) Active immunization – with 1 mL tetanus toxoid
to be repeated after 3 months,
 For prevention of tetanus neonatorum and
puerperal tetanus the pregnant woman must be
vaccinated against tetanus unless she has received
a booster dose within the previous 5 years.
 (b) Passive immunization – with toxoid,
immunoglobulin for all clean and minor wounds,
and toxoid immunoglobulin plus antibiotic or
metronidazole for infected wounds
P/B :- DR NIYATI PATEL
12
Destruction of spores
 e.g. in operation theatres by filtered ventilation and
by use of antiseptics on floors and walls
 Autoclaving of surgical instruments and dressings.
 Iodine for skin decontamination.
Treatment of wounds
 Thorough cleaning, removal of foreign material and
debridement of necrotic tissue.
 Use of antimicrobials.
P/B :- DR NIYATI PATEL
13
THANK
YOU
P/B :- DR NIYATI PATEL
14

20.TETANUS.pdf

  • 1.
  • 2.
    DEFINATION Tetanus is causedby a powerful neurotoxin (tetanospasmin) produced by strains of “Clostridium tetani” when introduced into the tissues that blocks the inhibitory “synapses on motor neurons in CNS”, resulting in unrestrained reflex spasm. P/B :- DR NIYATI PATEL 2
  • 3.
    PATHOLOGY  The toxintravels up local motor axons from the site of infection  causing local tetanus and spreads through the blood stream  to reach many axons and hence the CNS.  Cranial nerves are usually affected because they are shorter  hence the common initial presentation is lock-jaw. P/B :- DR NIYATI PATEL 3
  • 4.
    PREDISPOSING FACTORS  Puncturedor war wounds.  Otitis media.  Unsterile surgery including use of infected cat gut and swabs, criminal abortions, ritual circumcision, and ear piercing.  Bowel surgery and infarction of bowel.  Burns.  Animal bites and stings.  Firework injuries.  Intra-uterine death.  Unsterile division of umbilical cord.  Compound fractures.  Miscellaneous – Chronic skin ulcers, plaster sores, gangrenous limbs, eye infections, human bites, dental extractions. P/B :- DR NIYATI PATEL 4
  • 5.
    CLINICAL FEATURES  Incubationperiod – usually 6 to 10 days, rarely several months.  Clinical Features 1. Prodromal symptoms – Nonspecific such as malaise, fever, sweating, headache and irritability. 2. Presenting symptoms – Trismus (lock jaw) and dysphagia (often described as sore throat) due to painful rigidity of masseters and muscles of deglutition. Pain and stiffness in the neck and back. 3. Symptoms of established disease – Rigidity, muscle spasms, symptoms due to sympathetic overactivity P/B :- DR NIYATI PATEL 5
  • 6.
    CLINICAL VARIANTS  LOCALTETANUS  INJURY OF LIMB  ASCENDING FORM  LOCAL SPASM  CEPHALIC TETANUS  HEAD & NECK INJURY & INFECTIONS OF EYE & ORBIT  7TH CN AFFECTED  SPLANCHNIC TETANUS  ABDOMINAL / THORACIC WOUND  MAINLY POST OPERATIVE  NEONATAL TETANUS  DUE TO UMBILICAL STUMP P/B :- DR NIYATI PATEL 6
  • 7.
    SEVERITY OF TETANUSGRADING  GRADE- 1 (MILD) Mild & moderate lock jaw, generalized spasticity, no spasms / respiratory difficulty  GRADE-2 (MODERATE)  Well marked rigidity, brief spasm, mild dysphagia, tachypnoea  GRADE-3 (SEVERE) Severe trismus, generalized spasticity, prolonged spasms often spontaneous, tachypnoea (> 40/min), apnoeic spells, marked dysphagia, tachycardia  GRADE-4 (VERY SEVERE)  severe hypertension and tachycardia alternating with relative hypotension and bradycardia, or severe persistent hypertension or hypotension. P/B :- DR NIYATI PATEL 7
  • 8.
    DIAGNOSIS  Is confirmedby microbiology. A tissue sample (preferably) or a swab of the wound site is taken for Gram-staining and anaerobic culture.  Cultures of C. tetani are tested for toxin production P/B :- DR NIYATI PATEL 8
  • 9.
    MANAGEMENT  Neutralization ofunbound toxin – Hyperimmune human anti- tetanus immunoglobulin  Reduction of further toxin production –  (a) Care of the wound – Removal of foreign material and debridement of non-viable tissue of entry wound.  (b) Antibiotic – Benzyl penicillin / erythromycin  Control of rigidity & tetanic seizures  (a) Avoidance of provocative stimuli –such as noise, unnecessary movement, and keeping injections to minimum.  (b) Sedative drugs – Diazepam, chlorpromazine, morphine sulphate  (c) Tracheostomy  not controlled with conservative sedative regimen  (d) Induced paralysis with ventilatory support – Neuroparalytic agents pancuronium P/B :- DR NIYATI PATEL 9
  • 10.
     Nursing support–  (a) ICU – Moderate and severe cases should be nursed in ICU.  (b) Nutrition – Continuous drip feeding via nasogastric or nasojejunal tube.  General measures and physiotherapy – to prevent bed sores and complications of prolonged unconsciousness.  Low molecular weight heparin  to prevent deep vein thrombosis. P/B :- DR NIYATI PATEL 10
  • 11.
     Management accordingto severity of tetanus –  Mild: Sedatives + Muscle relaxants  Moderate: Sedatives + Muscle relaxants + tracheostomy  Severe: Sedatives + tracheostomy + neuromuscular paralytic agents + ventilatory support P/B :- DR NIYATI PATEL 11
  • 12.
    PREVENTION 1. Immunization – (a) Active immunization – with 1 mL tetanus toxoid to be repeated after 3 months,  For prevention of tetanus neonatorum and puerperal tetanus the pregnant woman must be vaccinated against tetanus unless she has received a booster dose within the previous 5 years.  (b) Passive immunization – with toxoid, immunoglobulin for all clean and minor wounds, and toxoid immunoglobulin plus antibiotic or metronidazole for infected wounds P/B :- DR NIYATI PATEL 12
  • 13.
    Destruction of spores e.g. in operation theatres by filtered ventilation and by use of antiseptics on floors and walls  Autoclaving of surgical instruments and dressings.  Iodine for skin decontamination. Treatment of wounds  Thorough cleaning, removal of foreign material and debridement of necrotic tissue.  Use of antimicrobials. P/B :- DR NIYATI PATEL 13
  • 14.
    THANK YOU P/B :- DRNIYATI PATEL 14